A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

Administered By

Awarded By

Contributors

Start/End

  • November 1, 2013 - October 31, 2015